Fistula - Pipeline Review, H2 2011 by GlobalMarketsDirect

VIEWS: 0 PAGES: 25

More Info
									Fistula – Pipeline Review, H2 2011




                                   Fistula - Pipeline Review, H2 2011
                                                                                          Reference Code: GMDHC1591IDB

                                                                                          Publication Date: November 2011




Fistula – Pipeline Review, H2 2011                                                                            GMDHC1591IDB / Pub November 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                                                Page(1)
Fistula – Pipeline Review, H2 2011



Ta b le o f Co n te n ts
Table of Contents ..................................................................................................................................................................................................... 2
      List of Tables...................................................................................................................................................................................................... 3
      List of Figures .................................................................................................................................................................................................... 3
Introduction .............................................................................................................................................................................................................. 4
      Global Markets Direct Report Coverage ............................................................................................................................................................. 4
Fistula Overview ....................................................................................................................................................................................................... 5
Therapeutics Development ....................................................................................................................................................................................... 6
      An Overview of Pipeline Products for Fistula ...................................................................................................................................................... 6
Fistula Therapeutics under Development by Companies .......................................................................................................................................... 8
Fistula Therapeutics under Investigation by Universities/Institutes ............................................................................................................................ 9
Late Stage Products ................................................................................................................................................................................................10
      Comparative Analysis .......................................................................................................................................................................................10
Mid Clinical Stage Products .....................................................................................................................................................................................11
      Comparative Analysis .......................................................................................................................................................................................11
Fistula Therapeutics - Products under Development by Companies ........................................................................................................................12
Fistula Therapeutics - Products under Investigation by Universities/Institutes ..........................................................................................................13
Fistula - Therapeutics Assessment ..........................................................................................................................................................................14
      Assessment by Monotherapy Products .............................................................................................................................................................14
      Assessment by Combination Products ..............................................................................................................................................................15
      Assessment by Route of Administration ............................................................................................................................................................16
      Assessment by Molecule Type ..........................................................................................................................................................................18
Drug Profiles ...........................................................................................................................................................................................................20
      Adalimumab + Ciprofloxacin - Drug Profile ........................................................................................................................................................20
            Product Description ....................................................................................................................................................................................20
            Mechanism of Action...............................................................
								
To top